Japan has given the green light to two trailblazing stem-cell treatments one targeting Parkinson’s disease and another aimed at severe heart failure, according to the manufacturer and local media reports published Friday (March 6). Both therapies could be in patients’ hands within a matter of months. Pharmaceutical company Sumitomo Pharma announced regulatory approval to produce … Continue reading Japan Approves Two Groundbreaking Stem-Cell Therapies for Parkinson’s and Heart Failure